 |
 |
|
|
|  PubMed
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 May 2004 | Volume 140 Issue 9 | Pages 740-753
Background: Lung cancer is the leading cause of cancer-related death in the United States and worldwide. No major professional organizations, including the U.S. Preventive Services Task Force (USPSTF), currently recommend screening for lung cancer.
Purpose: To examine the evidence evaluating screening for lung cancer with chest radiography, sputum cytologic examination, and low-dose computed tomography (CT) to aid the USPSTF in updating its recommendation on lung cancer screening.
Data Sources: MEDLINE, the Cochrane Library, reviews, editorials, and experts.
Study Selection: Studies that evaluated mass screening programs for lung cancer involving the tests of interest were selected. All studies were reviewed, but only studies with control groups were rated in quality since these would most directly influence the USPSTF screening recommendation.
Data Extraction: Data were abstracted to data collection forms. Studies were graded according to criteria developed by the USPSTF.
Data Synthesis: None of the 6 randomized trials of screening for lung cancer with chest radiography alone or in combination with sputum cytologic examination showed benefit among those screened. All studies were limited because some level of screening occurred in the control population. Five case–control studies from Japan suggested benefit to both high- and low-risk men and women. All studies were limited by potential healthy screenee bias. Six cohort studies showed that when CT was used to screen for lung cancer, lung cancer was diagnosed at an earlier stage than in usual clinical care. However, these studies did not have control groups, making mortality evaluation difficult. In addition, the studies demonstrated a high rate of false-positive findings.
Conclusions: Current data do not support screening for lung cancer with any method. These data, however, are also insufficient to conclude that screening does not work, particularly in women. Two randomized trials of screening with chest radiography or low-dose CT are currently under way and will better inform lung cancer screening decisions.
Author and Article Information
From Oregon Health & Science University Evidence-based Practice Center and Portland Veterans Affairs Medical Center, Portland, Oregon; Merck & Co., West Point, Pennsylvania; and University of Medicine and Dentistry of New Jersey Medical School, Newark, New Jersey.
Disclaimer: The authors of this article are responsible for its contents, including any clinical or treatment recommendations. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality, the U.S. Department of Health and Human Services, or Merck & Co., Inc.
Acknowledgments: The authors thank Kathryn Krages, AMLS, MA; Susan Wingenfeld; and Kim Peterson, MS, for their help in preparation of the full evidence report and the manuscript. They also thank Mark Helfand, MD, MPH; William Holden, MD; John McAnulty, MD; and James Reuler, MD, for their helpful reviews of the manuscript.
Grant Support: This study was conducted by the Oregon Health & Science University Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality (contract no. 290-97-0018, Task Order 2, Rockville, Maryland).
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Reprints are available from the Agency for Healthcare Research and Quality Web site (http://www.preventiveservices.ahrq.gov) and through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358-9295).
Current Author Addresses: Dr. Humphrey: Oregon Health & Science University, Mailcode BICC, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098.
Dr. Teutsch: Merck & Co., Inc., Sumneytown Pike and Broad Street, PO Box 4, West Point, PA 19437.
Dr. Johnson: Department of Family Medicine, University of Medicine and Dentistry–New Jersey Medical School, 185 South Orange Avenue, MSB-B648, Newark, NJ 07103. CLINICAL GUIDELINES
Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  R. K. Gill, M. F. Vazquez, A. Kramer, M. Hames, L. Zhang, K. Heselmeyer-Haddad, T. Ried, K. Shilo, C. Henschke, D. Yankelevitz, et al. The Use of Genetic Markers to Identify Lung Cancer in Fine Needle Aspiration Samples Clin. Cancer Res., November 15, 2008; 14(22): 7481 - 7487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Mulshine Commentary: Lung Cancer Screening--Progress or Peril Oncologist, April 1, 2008; 13(4): 435 - 438. [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Yankelevitz, W. C. Black, D. R. Aberle, C. D. Berg, and on behalf of the Executive Committee of the Nation Will the National Lung Screening Trial Be Able to Demonstrate a Mortality Reduction? Radiology, February 1, 2008; 246(2): 653 - 654. [Full Text] [PDF]
|
|
|
|
 |
|
 International Early Lung Cancer Action Program Inv Computed tomographic screening for lung cancer: individualising the benefit of the screening Eur. Respir. J., November 1, 2007; 30(5): 843 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Sedjo, T. Byers, E. Barrera Jr., C. Cohen, E. T. H. Fontham, L. A. Newman, C. D. Runowicz, A. G. Thorson, M. J. Thun, E. Ward, et al. A Midpoint Assessment of the American Cancer Society Challenge Goal to Decrease Cancer Incidence by 25% Between 1992 and 2015 CA Cancer J Clin, November 1, 2007; 57(6): 326 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Veronesi, M. Bellomi, U. Veronesi, G. Paganelli, P. Maisonneuve, P. Scanagatta, F. Leo, G. Pelosi, L. Travaini, C. Rampinelli, et al. Role of Positron Emission Tomography Scanning in the Management of Lung Nodules Detected at Baseline Computed Tomography Screening Ann. Thorac. Surg., September 1, 2007; 84(3): 959 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Parimon, J. W. Chien, C. L. Bryson, M. B. McDonell, E. M. Udris, and D. H. Au Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Black, R. de Verteuil, S. Walker, J. Ayres, A. Boland, A. Bagust, and N. Waugh Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature Thorax, February 1, 2007; 62(2): 131 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schoder and M. Gonen Screening for Cancer with PET and PET/CT: Potential and Limitations J. Nucl. Med., January 1, 2007; 48(1_suppl): 4S - 18S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yasufuku, T. Nakajima, K. Motoori, Y. Sekine, K. Shibuya, K. Hiroshima, and T. Fujisawa Comparison of Endobronchial Ultrasound, Positron Emission Tomography, and CT for Lymph Node Staging of Lung Cancer. Chest, September 1, 2006; 130(3): 710 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Black Randomized Clinical Trials for Cancer Screening: Rationale and Design Considerations for Imaging Tests J. Clin. Oncol., July 10, 2006; 24(20): 3252 - 3260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Ganti and J. L. Mulshine Lung cancer screening. Oncologist, May 1, 2006; 11(5): 481 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Weinberger Update in pulmonary medicine. Ann Intern Med, March 7, 2006; 144(5): 358 - 363. [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Leader, T. E. Warfel, C. R. Fuhrman, S. K. Golla, J. L. Weissfeld, R. S. Avila, W. D. Turner, and B. Zheng Pulmonary Nodule Detection with Low-Dose CT of the Lung: Agreement Among Radiologists Am. J. Roentgenol., October 1, 2005; 185(4): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Mulshine Clinical Issues in the Management of Early Lung Cancer Clin. Cancer Res., July 1, 2005; 11(13): 4993s - 4998s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Mulshine and D. C. Sullivan Lung Cancer Screening N. Engl. J. Med., June 30, 2005; 352(26): 2714 - 2720. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Mulshine New Developments in Lung Cancer Screening J. Clin. Oncol., May 10, 2005; 23(14): 3198 - 3202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Strauss, L. Dominioni, J. R. Jett, M. Freedman, and F. W. Grannis Jr Como International Conference Position Statement: Lung Cancer Screening for Early Diagnosis 5 Years After The 1998 Varese Conference Chest, April 1, 2005; 127(4): 1146 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Jaffer and R. Weissleder Molecular Imaging in the Clinical Arena JAMA, February 16, 2005; 293(7): 855 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Petty Screening for Lung Cancer Ann Intern Med, October 19, 2004; 141(8): 649 - 650. [Full Text] [PDF]
|
|
|
|
|
|
Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 691 - 715. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Mulshine and J. N. Weinstein Is the Gene Expression Pattern of Lung Cancer Detected by Screening With Spiral Computed Tomography Different from That of Symptom-Detected Lung Cancer? Clin. Cancer Res., September 15, 2004; 10(18): 5973 - 5974. [Full Text] [PDF]
|
|
|
|
 |
|
 Other articles noted Evid. Based Med., September 1, 2004; 9(5): e5 - e5. [Full Text] [PDF]
|
|
|
|
|
|
Other articles noted Evid. Based Med., September 1, 2004; 9(5): 159 - 160. [Full Text] [PDF]
|
|
|
|
 |
|
 Screening for Lung Cancer: Insufficient Evidence Journal Watch (General), May 21, 2004; 2004(521): 2 - 2. [Full Text]
|
|
